GlassScriptPhysician profile
Dipan Patel
NPI 1689939548
$49,676.25
in general payments reported to CMS, 2019-2025
48 companies · $4,347 in 2025
The $4,347 reported for 2025 was more than what 92% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $7,676 · 2021: $1,965 · 2022: $3,789 · 2023: $1,178 · 2024: $2,552 · 2025: $4,347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,012 · Entertainment: $43.10 · Travel and Lodging: $22.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,011.92 |
| Entertainment | $43.10 |
| Travel and Lodging | $22.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17,644.24 | 2019-2020 | |
| Boston Scientific Corporation | $9,480.10 | 2019-2025 | General - Pain Management, Intracept Rf Probe, Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $4,247.05 | 2019-2020 | |
| Mml US, INC. | $3,537.96 | 2021-2025 | Reactiv8 |
| Medtronic, INC. | $2,222.28 | 2021-2025 | Mazor X System, Infinity Occipitocervical Upper Thoracic System, Intellis Adaptivestim |
| Biotronik Nro, INC. | $2,043.68 | 2024-2025 | Prospera |
| Vertiflex, INC. | $1,816.45 | 2019 | |
| Medtronic Vascular, INC. | $1,239.12 | 2019 | |
| Vertos Medical, INC. | $704.10 | 2019-2023 | Mild Device Kit |
| Saluda Medical Americas, INC. | $660.70 | 2023-2024 | Evoke, Evoke Scs |
| Spr Therapeutics, INC | $644.74 | 2019-2025 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $575.66 | 2021-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $545.33 | 2020-2025 | Relistor |
| Nevro Corp. | $391.55 | 2019-2022 | |
| Nalu Medical, INC. | $323.86 | 2020 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $285.21 | 2019-2024 | Twistr, Monovisc |
| Painteq LLC | $265.37 | 2023-2024 | Painteq |
| Tersera Therapeutics LLC | $264.77 | 2019-2025 | Prialt |
| Stryker Corporation | $232.24 | 2021-2024 | Vitoss |
| Kowa Pharmaceuticals America, INC. | $227.14 | 2022-2023 | Seglentis |
| Si-Bone, INC. | $221.71 | 2019-2022 | |
| Foundation Fusion Solutions, LLC | $218.02 | 2022-2025 | |
| Flowonix Medical Incorporated | $211.80 | 2019 | |
| Abbvie INC. | $177.56 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $153.27 | 2021-2025 | Xtampza |
| Allergan, INC. | $135.50 | 2019-2022 | |
| Theragen, INC. | $128.00 | 2025 | Actastim-S |
| Curonix LLC | $119.15 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Seapearl East, INC | $110.07 | 2022-2024 | |
| Nuvasive, INC. | $105.57 | 2020 | |
| Virtus Pharmaceuticals LLC | $101.56 | 2021-2025 | Levorphanol Tartrate |
| Biodelivery Sciences International, INC. | $89.48 | 2019-2020 | |
| Intrinsic Therapeutics | $89.42 | 2025 | Barricaid Acd (Annular Closure Device) |
| Forte Bio-Pharma LLC | $60.00 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Zyla Life Sciences, INC. | $55.33 | 2019-2020 | |
| Averitas Pharma INC. | $53.69 | 2023-2025 | Qutenza |
| Almatica Pharma LLC | $43.36 | 2023 | Gralise |
| Stratus Medical, LLC | $42.75 | 2020 | |
| Smith+Nephew, INC. | $35.21 | 2024 | Lens 4k |
| Djo, LLC | $29.36 | 2022 | |
| Redhill Biopharma INC. | $25.36 | 2020-2021 | |
| Axonics, INC. | $21.89 | 2022 | |
| Sanara Medtech INC. | $20.43 | 2025 | Celleraterx |
| Medtronic USA, INC. | $18.12 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $17.12 | 2025 | |
| Medline Industries LP | $15.08 | 2023 | |
| Pfizer INC. | $13.64 | 2019 | |
| Pacira Therapeutics, INC. | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.